SPECT/CT淋巴显像引导简化并改善新辅助化疗后初始淋巴结阳性乳腺癌夹子淋巴结的靶向腋窝清扫
研究纳入15例新辅助化疗前临床淋巴结阳性、活检证实腋窝淋巴结转移并放置夹子的乳腺癌患者,术后行99mTc-纳米胶体SPECT/CT淋巴显像定位夹子淋巴结。12/15例(80%)夹子淋巴结放射性摄取,仅3例(20%)需导丝引导定位,夹子淋巴结取出成功率100%。作者认为该技术似可行,可简化并改善靶向腋窝清扫,需进一步研究以适配临床实践。
要点
- 15例中12例(80%)夹子淋巴结在SPECT/CT淋巴显像上呈放射性摄取。
- 5例(33.3%)夹子淋巴结未蓝染,其中2例在SPECT/CT上仍有放射性摄取。
- 仅3例(20%)因夹子淋巴结无放射性摄取/蓝染需导丝引导定位,取出成功率100%。
核心结论
- SPECT/CT淋巴显像似可在多数患者术中确定夹子淋巴结而无需额外侵入性方法。
- 该技术简化并改善新辅助化疗后初始淋巴结阳性乳腺癌的靶向腋窝清扫,作者认为可经进一步研究适配临床实践。
研究设计与样本
- 纳入15例新辅助化疗前临床淋巴结阳性、活检证实腋窝淋巴结转移并放置夹子的乳腺癌患者。
- 新辅助化疗后手术前行99mTc-纳米胶体SPECT/CT淋巴显像定位夹子淋巴结并评估其放射性摄取。
- 夹子淋巴结无摄取者转行导丝引导定位,同时注射蓝染料用于前哨淋巴结活检双重定位。
主要发现
- 所有患者仅有同侧腋窝淋巴结转移。
- SPECT/CT淋巴显像显示15例中12例(80%)夹子淋巴结呈放射性摄取。
- 5例(33.3%)夹子淋巴结未蓝染,其中2例在SPECT/CT上夹子淋巴结呈放射性摄取。
- 仅3例(20%)因夹子淋巴结无放射性摄取/蓝染需导丝引导定位。
- 所有病例均经标本摄影证实夹子淋巴结被取出,成功率100%。
临床怎么用
- 作者认为SPECT/CT淋巴显像似可在多数患者术中确定夹子淋巴结而无需额外侵入性方法。
- 作者认为该技术简化并改善新辅助化疗后初始淋巴结阳性乳腺癌的靶向腋窝清扫,可经进一步研究适配临床实践。
局限性
- 原文结论使用「seems feasible」并写明「can be adapted to clinical practice with further investigations」,提示需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We assessed the feasibility of SPECT/CT lymphoscintigraphy ( 99m Tc-nanocolloid) method to simplify and improve targeted axillary dissection of clipped axillary lymph node (axLN) after neoadjuvant chemotherapy (NAC) in initially node-positive breast cancer. PATIENTS AND METHODS: Fifteen patients who had clip placement to biopsy-confirmed axLN metastasis due to clinically node-positive breast cancer before NAC and underwent SPECT/CT lymphoscintigraphy for surgery after NAC were included into the study. SPECT/CT lymphoscintigraphy was performed to localize the clipped node and to assess if the clipped lymph node (LN) had 99m Tc-nanocolloid uptake or not. In case the clipped node had no uptake on SPECT/CT, the patient was referred to wire-guided localization procedure. Blue dye was also injected for dual mapping of sentinel LN biopsy. RESULTS: All patients had only ipsilateral axLN metastasis. SPECT/CT lymphoscintigraphy showed that clipped LNs were radioavid in 12 of 15 patients (80%). Clipped LNs were not blue-stained in 5 patients (33.3%), and in 2 of them, clipped LNs were radioavid in SPECT/CT. Wire-guided localization was required in only 3 patients (20%) for nonradioavid/blue-stained clipped LNs. Removal of the clipped nodes was confirmed in all cases with a success rate of 100% by specimen graphy. CONCLUSION: SPECT/CT lymphoscintigraphy seems feasible to determine the clipped LNs intraoperatively without requiring additional invasive methods in most of the patients. This technique simplifies and improves targeted axillary dissection of the clipped axLNs after NAC in initially node-positive breast cancer and can be adapted to clinical practice with further investigations.
引用
- Has Simsek D, Emiroglu S, Yilmaz R, et al. SPECT/CT Lymphoscintigraphy Guidance Simplifies and Improves Targeted Axillary Dissection of the Clipped Nodes After Neoadjuvant Chemotherapy in Initially Node-Positive Breast Cancer. Clin Nucl Med. 2022. PMID: 35835147. doi:10.1097/RLU.0000000000004340
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。